about
Sleep and immune functionStrawberry notch homolog 2 is a novel inflammatory response factor predominantly but not exclusively expressed by astrocytes in the central nervous systemHER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesisIL-6 Plays a Crucial Role in HBV InfectionThe Regulation of CD4(+) T Cell Responses during Protozoan InfectionsTherapeutic strategies for the clinical blockade of IL-6/gp130 signalingAlterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseasesPrevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptorCrystal Structure of Interleukin-6 in Complex with a Modified Nucleic Acid LigandRefining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous TocilizumabExpression of pancreatitis-associated protein after traumatic brain injury: a mechanism potentially contributing to neuroprotection in human brainExpression profiling and Ingenuity biological function analyses of interleukin-6- versus nerve growth factor-stimulated PC12 cellsAlternative intronic polyadenylation generates the interleukin-6 trans-signaling inhibitor sgp130-E10Interleukin-6 (IL-6) receptor/IL-6 fusion protein (Hyper IL-6) effects on the neonatal mouse brain: possible role for IL-6 trans-signaling in brain development and functional neurobehavioral outcomesRole of cytokine signaling during nervous system developmentThe transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitisIL-13 receptor alpha2 regulates the immune and functional response to Nippostrongylus brasiliensis infectionInduction of the interleukin 6/ signal transducer and activator of transcription pathway in the lungs of mice sub-chronically exposed to mainstream tobacco smoke.Association between inflammatory components and physical function in the health, aging, and body composition study: a principal component analysis approach.Interleukin (IL)-1 and IL-6 regulation of neural progenitor cell proliferation with hippocampal injury: differential regulatory pathways in the subgranular zone (SGZ) of the adolescent and mature mouse brain.Kidney dysfunction in patients with pulmonary arterial hypertensionSerum soluble glycoprotein 130 concentration is inversely related to insulin sensitivity in women with polycystic ovary syndrome.Inducible STAT3 NH2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosisIL-6 and high glucose synergistically upregulate MMP-1 expression by U937 mononuclear phagocytes via ERK1/2 and JNK pathways and c-Jun.Structural pathways of cytokines may illuminate their roles in regulation of cancer development and immunotherapy.Soluble gp130 promotes intestinal epithelial hyperplasia during reovirus infection.The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation.Granzymes in age-related cardiovascular and pulmonary diseases.Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis.Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells.Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1β production in macrophages by targeting STAT3.A role for IL-27p28 as an antagonist of gp130-mediated signaling.Elevated maternal soluble Gp130 and IL-6 levels and reduced Gp130 and SOCS-3 expressions in women complicated with preeclampsia.Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behaviorA novel rapid (20-minute) IL-6 release assay using blood mononuclear cells of patients with various clinical forms of drug induced skin injuriesInterleukin-6 and chronic inflammationgp130 cytokines are positive signals triggering changes in gene expression and axon outgrowth in peripheral neurons following injury.Altered interleukin-6 receptor, IL-6R and gp130, production and expression and decreased SOCS-3 expression in placentas from women with pre-eclampsia.Effects of hyaluronan treatment on lipopolysaccharide-challenged fibroblast-like synovial cells.IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling.
P2860
Q22337448-CA8BD978-8BEB-4DBF-9F11-3302A58EB3A4Q24337059-53B7F117-E4EE-4FD9-9257-DAD7A3F1F00CQ24598092-285EF090-E3CB-4582-BF0D-D6B52F48A008Q26774879-029BF825-8BC3-44A5-BC88-D0D294F08BF9Q26865518-0DB2B579-093B-48BE-B17B-DE92244C1651Q27002391-5CC29EDD-2043-4F6F-9D30-2D8BC424C3F0Q27016000-E8146463-FED3-43F9-A13C-2F6C861E6CBAQ27022976-D7164584-8580-4C8B-B444-59FAAE74C7E2Q27681282-BB0CADC1-9F98-47BA-BE73-69E0ECE6BA34Q28080677-0B06F638-6951-4C4E-84A2-755CCF976125Q28566140-D94211E3-AA83-47C3-AB8A-3ADDE8EFD608Q28581575-3D6A0C39-687A-4D25-93F4-AAE377E0A2F0Q28654409-D23FF0C6-F4D8-44CC-B253-A87463B77E3CQ30445005-3E7C557B-5557-485B-B99D-EE3A62B96AB8Q30450870-1698849D-358B-4C93-89A4-48EEB983D27AQ30483252-D1E55CBC-B8DD-430F-B4EC-EE2BF5F1EF8EQ33479866-11ECF26E-53CB-4F53-9B7B-15EF84B4EA7BQ33495694-FAE51AF4-694C-4DFD-936C-AA2899E0F691Q33567643-A800F63F-73A5-427C-907D-1E9ECBE66F99Q33690316-EAB5B09F-3FB4-4C99-8BDC-060540100C35Q33738621-9AF254D4-D95B-498B-B44C-99F900D0576BQ33750620-6E0E9DBE-5D93-44CD-B0F3-67C5009C4112Q33792527-C848CC53-2097-4957-8358-134E2628F053Q33806982-D37EC35F-344D-4208-9A7D-9D8B3BB89976Q33820227-5F99E587-BC76-460C-AEFD-6870CC93C274Q33907743-110942FC-0669-41FD-BF1B-A00DB7A1489CQ34030580-E90F648D-8957-4B60-8D88-227C6AE6BB03Q34097453-057DAD73-6879-4422-8EBD-40550384B10DQ34152981-4A1A90E3-B5A2-4431-9AD9-9C850595B2E0Q34196062-43BEAB1E-9E3B-4AD2-9553-F3B25E952897Q34398929-4FF049DA-120D-4A88-90CA-DA5B5ED9E7CBQ34688139-5DF17A5D-BF71-4BE5-B3B5-1F684C24D79CQ34707068-4E4F82CE-8C2C-4E38-96B2-6A59CE8479B3Q35040208-542450C6-2192-4993-9F81-3502752CDB93Q35078628-4E5172B1-E5C3-4C1F-BA7D-88F8968FBF2AQ35578869-4D9A0816-DDD2-45B7-9964-3E9CA194BA5FQ35683496-0EE321D3-761F-416D-8A5D-25BF145C2C7FQ35738082-141FD26E-A4CF-4CD5-94AC-764C45AC9AF3Q35769032-2EC41941-10D5-43BC-8C11-7A22CC6A55CBQ35787352-EE24C4E9-CCFC-4D22-AE2A-9FB3E295339C
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
IL-6 transsignaling: the in vivo consequences.
@ast
IL-6 transsignaling: the in vivo consequences.
@en
type
label
IL-6 transsignaling: the in vivo consequences.
@ast
IL-6 transsignaling: the in vivo consequences.
@en
prefLabel
IL-6 transsignaling: the in vivo consequences.
@ast
IL-6 transsignaling: the in vivo consequences.
@en
P356
P1476
IL-6 transsignaling: the in vivo consequences.
@en
P2093
Jürgen Scheller
Peter J Richards
P304
P356
10.1089/JIR.2005.25.241
P577
2005-05-01T00:00:00Z